Provided by Tiger Fintech (Singapore) Pte. Ltd.

Osisko Gold Royalties

25.92
-0.5600-2.11%
Post-market: 25.920.00000.00%19:24 EDT
Volume:997.20K
Turnover:25.95M
Market Cap:4.86B
PE:157.35
High:26.60
Open:26.48
Low:25.73
Close:26.48
Loading ...

Osisko Gold Royalties (OR) Gets a Buy from RBC Capital

TIPRANKS
·
05 Jun

RBC Capital Adjusts Price Target on OR Royalties to $30 From $23, Maintains Outperform Rating

MT Newswires Live
·
04 Jun

OR Royalties Expands Portfolio with New Silver Stream Acquisition and Positive Asset Updates

TIPRANKS
·
03 Jun

Macquarie Keeps Their Hold Rating on SMC (OR) (SMECF)

TIPRANKS
·
28 May

Press Release: ChipMOS SHAREHOLDERS APPROVE NT$1.20 PER COMMON SHARE OR APPROXIMATELY US$0.80 PER ADS CASH DIVIDEND DISTRIBUTION

Dow Jones
·
28 May

Bernstein Remains a Buy on SMC (OR) (SMECF)

TIPRANKS
·
27 May

Helius to Spotlight Study Confirming Improved Long-Term Outcomes from Adherence to PoNS Therapy® at CMSC Annual Meeting

GlobeNewswire
·
20 May

Osisko Gold Royalties Rebrands to OR Royalties Inc.

TIPRANKS
·
09 May

RBC Capital Remains a Buy on Osisko Gold Royalties (OR)

TIPRANKS
·
08 May

Osisko Gold increases quarterly dividend 20% to 5.5c per share

TIPRANKS
·
08 May

Osisko Gold Royalties Q1 Adj. EPS $0.16, Inline, Sales $54.92M Miss $65.22M Estimate

Benzinga
·
08 May

Osisko Gold Royalties Ltd expected to post earnings of 17 cents a share - Earnings Preview

Reuters
·
06 May

Press Release: Tarsus Reports First Quarter 2025 Financial Results and Recent Business Achievements

Dow Jones
·
02 May

Press Release: CPKC reports first quarter results; solid demand, precision execution and a resilient network powers strong start to 2025

Dow Jones
·
01 May

XPO, Inc. (XPO): Among the Best Stocks to Buy According to D1 Capital’s Daniel Sundheim

Insider Monkey
·
29 Apr

Senti Bio’s SENTI-202, a First-in-Class Off-the-Shelf Logic Gated Selective CD33 OR FLT3 NOT EMCN CAR NK Cell Therapy, Demonstrates Positive Preliminary Clinical Results in the Treatment of Patients with Relapsed/Refractory AML

GlobeNewswire
·
28 Apr

LyondellBasell's Earnings Lag Estimates, Sales Beat in Q1

Zacks
·
25 Apr

Eastman Chemical's Earnings Surpass Estimates, Sales Miss in Q1

Zacks
·
25 Apr

Freeport-McMoRan's Earnings Match, Sales Beat Estimates in Q1

Zacks
·
24 Apr

DOW Beats on Q1 Earnings & Sales, Launches $6B Cash Support Actions

Zacks
·
24 Apr